Metsera to present new research highlighting the breadth and momentum of its next-generation obesity portfolio at the 85th scientific sessions of the american diabetes association®

Four presentations on met-097i, a fully biased, monthly, ultra-long acting glp-1 receptor agonist, including two clinical data presentations

MTSR Ratings Summary

MTSR Quant Ranking